Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival

D.M. Ferns, I.P. Kema, M.R. Buist, H.W. Nijman, G.G. Kenter, E.S. Jordanova

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article numbere981457
JournalOncoImmunology
Volume4
Issue number2
DOIs
Publication statusPublished - 2015

Cite this